India’s largest pharma company has caught investors’ fancy and a lot of it is due to founder Dilip Shanghvi’s need to take a different path.
Sun Pharmaceutical Industries’s market capitalization is back at Rs 240,000 crore. That’s just 12% shy of its best ever market capitalization of Rs 269,000 crore, which it hit in March 2015, making its founder Dilip Shanghvi India’s richest person for a brief while before Reliance Industries’s Mukesh Ambani took back the crown.
What makes the Sun Pharma stock stand out is that it has gained 18.3% in the last one year, at a time when the healthcare industry, represented by the BSE Healthcare index, fell 11.85%. Sun Pharma has also significantly outperformed the broader Nifty 50, which has risen 2.4% …
Surendar helps lead the newsroom at The Morning Context as executive editor. Over the years, Surendar has worked in industries from pharmaceuticals to diamonds, as well as a stint as an equity analyst. In his long career as a business journalist, he has led teams at The Times of India, India Today and Fortune India. He was part of the founding team at Forbes India and interned at and published in The Times, London.
Executive Editor
surendar@mailtmc.com
Mumbai